BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32953149)

  • 1. Impact of immunotherapy use in patients with stage IV pancreatic carcinoma.
    Guddati AK; Komiya T; Patel SJ; Sharma N; Powell E
    J Gastrointest Oncol; 2020 Aug; 11(4):654-662. PubMed ID: 32953149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Immunotherapy in Stage IV Large Cell Neuroendocrine Carcinoma of the Lung.
    Komiya T; Ravindra N; Powell E
    Asian Pac J Cancer Prev; 2021 Feb; 22(2):365-370. PubMed ID: 33639649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of stage IV melanoma in the era of immunotherapy: a National Cancer Database (NCDB) analysis from 2014 to 2016.
    Sussman TA; Knackstedt R; Wei W; Funchain P; Gastman BR
    J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 35998982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy versus observation following neoadjuvant therapy and surgery for resectable stage I-II pancreatic cancer.
    Ma SJ; Serra LM; Bartl AJ; Han HR; Fekrmandi F; Iovoli AJ; Hermann GM; Yu H; Singh AK
    J Radiother Pract; 2022 Sep; 21(3):383-392. PubMed ID: 36016861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinoma.
    Corrigan KL; Xu T; Sasaki Y; Lin R; Chen AB; Welsh JW; Lin SH; Chang JY; Ning MS; Gandhi S; O'Reilly MS; Gay CM; Altan M; Lu C; Cascone T; Koutroumpakis E; Sheshadri A; Zhang X; Liao L; Zhu XR; Heymach JV; Nguyen QN; Liao Z
    Radiother Oncol; 2024 Apr; 193():110121. PubMed ID: 38311031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival in Metastatic Renal Cell Carcinoma Treated With Immunotherapy and Stereotactic Radiation Therapy or Immunotherapy Alone: A National Cancer Database Analysis.
    Piening A; Al-Hammadi N; Dombrowski J; Hamilton Z; Teague RM; Swaminath A; Shahi J
    Adv Radiat Oncol; 2023; 8(5):101238. PubMed ID: 37408680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I-II or unresected stage III pancreatic cancer.
    Ma SJ; Iovoli AJ; Hermann GM; Prezzano KM; Singh AK
    Cancer Med; 2019 Aug; 8(9):4110-4123. PubMed ID: 31183965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of neoadjuvant and adjuvant immunotherapy on the survival of pancreatic cancer patients: a retrospective analysis.
    Amin S; Baine M; Meza J; Lin C
    BMC Cancer; 2020 Jun; 20(1):538. PubMed ID: 32517661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Liver Metastasis on First-Line Immunotherapy in Stage IV Non-Small Cell Lung Cancer.
    Komiya T; Takamori S; Shimokawa M
    World J Oncol; 2023 Aug; 14(4):234-245. PubMed ID: 37560341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation.
    Zhong J; Patel K; Switchenko J; Cassidy RJ; Hall WA; Gillespie T; Patel PR; Kooby D; Landry J
    Cancer; 2017 Sep; 123(18):3486-3493. PubMed ID: 28493288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant chemotherapy versus chemoradiation in high-risk pancreatic adenocarcinoma: A propensity score-matched analysis.
    Raoof M; Blakely AM; Melstrom LG; Lee B; Warner SG; Chung V; Singh G; Chen YJ; Fong Y
    Cancer Med; 2019 Oct; 8(13):5881-5890. PubMed ID: 31414566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer.
    Galli G; De Toma A; Pagani F; Randon G; Trevisan B; Prelaj A; Ferrara R; Proto C; Signorelli D; Ganzinelli M; Zilembo N; de Braud F; Garassino MC; Lo Russo G
    Lung Cancer; 2019 Nov; 137():38-42. PubMed ID: 31526910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy.
    Bilen MA; Shabto JM; Martini DJ; Liu Y; Lewis C; Collins H; Akce M; Kissick H; Carthon BC; Shaib WL; Alese OB; Steuer CE; Wu C; Lawson DH; Kudchadkar R; Master VA; El-Rayes B; Ramalingam SS; Owonikoko TK; Harvey RD
    BMC Cancer; 2019 Aug; 19(1):857. PubMed ID: 31464611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of breast surgery on survival of patients with stage IV breast cancer: a SEER population-based propensity score matching analysis.
    Lin Y; Huang K; Zeng Q; Zhang J; Song C
    PeerJ; 2020; 8():e8694. PubMed ID: 32219021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer.
    Ozer M; Goksu SY; Sanford NN; Porembka M; Khurshid H; Ahn C; Maxwell MC; Beg MS; Kazmi SM
    JAMA Netw Open; 2022 Feb; 5(2):e2146912. PubMed ID: 35171262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of immunotherapy on the survival of pancreatic adenocarcinoma patients who received definitive surgery of the pancreatic tumor: a retrospective analysis of the National Cancer Database.
    Amin S; Baine M; Meza J; Alam M; Lin C
    Radiat Oncol; 2020 Jun; 15(1):139. PubMed ID: 32493354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy followed by concurrent chemoradiation is associated with improved survival for resected stage I-II pancreatic cancer.
    Ma SJ; Hermann GM; Prezzano KM; Serra LM; Iovoli AJ; Singh AK
    Cancer Med; 2019 Mar; 8(3):939-952. PubMed ID: 30652417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival benefit from immunocheckpoint inhibitors in stage IV non-small cell lung cancer patients with brain metastases: A National Cancer Database propensity-matched analysis.
    Takamori S; Komiya T; Powell E
    Cancer Med; 2021 Feb; 10(3):923-932. PubMed ID: 33340271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival and prognostic factors in patients with pancreatic squamous cell carcinoma.
    Tella SH; Kommalapati A; Yadav S; Bergquist JR; Truty MJ; Durgin L; Ma WW; Cleary SP; McWilliams RR; Mahipal A
    Eur J Surg Oncol; 2019 Sep; 45(9):1700-1705. PubMed ID: 31118133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database analysis.
    Deng A; Wang C; Cohen SJ; Winter JM; Posey J; Yeo C; Basu Mallick A
    Eur J Cancer; 2021 Apr; 147():17-28. PubMed ID: 33607382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.